Literature DB >> 18679112

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.

Paul E Marik1, Howard L Corwin.   

Abstract

BACKGROUND: Red blood cell (RBC) transfusions are common in intensive care unit, trauma, and surgical patients. However, the hematocrit that should be maintained in any particular patient because the risks of further transfusion of RBC outweigh the benefits remains unclear.
OBJECTIVE: A systematic review of the literature to determine the association between red blood cell transfusion, and morbidity and mortality in high-risk hospitalized patients. DATA SOURCES: MEDLINE, Embase, Cochrane Register of Controlled Trials, and citation review of relevant primary and review articles. STUDY SELECTION: Cohort studies that assessed the independent effect of RBC transfusion on patient outcomes. From 571 articles screened, 45 met inclusion criteria and were included for data extraction. DATA EXTRACTION: Forty-five studies including 272,596 were identified (the outcomes from one study were reported in four separate publications). The outcome measures were mortality, infections, multiorgan dysfunction syndrome, and acute respiratory distress syndrome. The overall risks vs. benefits of RBC transfusion on patient outcome in each study was classified as (i) risks outweigh benefits, (ii) neutral risk, and (iii) benefits outweigh risks. The odds ratio and 95% confidence interval for each outcome measure was recorded if available. The pooled odds ratios were determined using meta-analytic techniques. DATA SYNTHESIS: Forty-five observational studies with a median of 687 patients/study (range, 63-78,974) were analyzed. In 42 of the 45 studies the risks of RBC transfusion outweighed the benefits; the risk was neutral in two studies with the benefits outweighing the risks in a subgroup of a single study (elderly patients with an acute myocardial infarction and a hematocrit <30%). Seventeen of 18 studies, demonstrated that RBC transfusions were an independent predictor of death; the pooled odds ratio (12 studies) was 1.7 (95% confidence interval, 1.4-1.9). Twenty-two studies examined the association between RBC transfusion and nosocomial infection; in all these studies blood transfusion was an independent risk factor for infection. The pooled odds ratio (nine studies) for developing an infectious complication was 1.8 (95% confidence interval, 1.5-2.2). RBC transfusions similarly increased the risk of developing multi-organ dysfunction syndrome (three studies) and acute respiratory distress syndrome (six studies). The pooled odds ratio for developing acute respiratory distress syndrome was 2.5 (95% confidence interval, 1.6-3.3).
CONCLUSIONS: Despite the inherent limitations in the analysis of cohort studies, our analysis suggests that in adult, intensive care unit, trauma, and surgical patients, RBC transfusions are associated with increased morbidity and mortality and therefore, current transfusion practices may require reevaluation. The risks and benefits of RBC transfusion should be assessed in every patient before transfusion.

Entities:  

Mesh:

Year:  2008        PMID: 18679112     DOI: 10.1097/CCM.0b013e3181844677

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  218 in total

1.  Liberal or restrictive transfusion in high-risk patients after hip surgery.

Authors:  Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner
Journal:  N Engl J Med       Date:  2011-12-14       Impact factor: 91.245

2.  Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?

Authors:  Pieter R Tuinman; Nicole P Juffermans
Journal:  Crit Care       Date:  2011-05-31       Impact factor: 9.097

3.  The risks of blood transfusion in patients with subarachnoid hemorrhage.

Authors:  Paul E Marik
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

4.  Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial.

Authors:  Daryl J Kor; Rahul Kashyap; Richard B Weiskopf; Gregory A Wilson; Camille M van Buskirk; Jeffrey L Winters; Michael Malinchoc; Rolf D Hubmayr; Ognjen Gajic
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

5.  Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot Study.

Authors:  Alexander A Hanke; Ulf Herold; Daniel Dirkmann; Konstantinos Tsagakis; Heinz Jakob; Klaus Görlinger
Journal:  Transfus Med Hemother       Date:  2012-03-15       Impact factor: 3.747

6.  The "sticky" business of "adherence" to transfusion guidelines.

Authors:  Alan T Tinmouth; Gregory M T Hare; C David Mazer
Journal:  Intensive Care Med       Date:  2010-05-04       Impact factor: 17.440

7.  CORR Insights(®): Can an Arthroplasty Registry Help Decrease Transfusions in Primary Total Joint Replacement? A Quality Initiative.

Authors:  Bryan D Springer
Journal:  Clin Orthop Relat Res       Date:  2015-08-18       Impact factor: 4.176

8.  Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial.

Authors:  D H de Gast-Bakker; R B P de Wilde; M G Hazekamp; V Sojak; J J Zwaginga; R Wolterbeek; E de Jonge; B J Gesink-van der Veer
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

Review 9.  Impact of the age of stored blood on trauma patient mortality: a systematic review.

Authors:  Nicholas Sowers; Patrick C Froese; Mete Erdogan; Robert S Green
Journal:  Can J Surg       Date:  2015-10       Impact factor: 2.089

10.  Association of Donor Age and Sex With Survival of Patients Receiving Transfusions.

Authors:  Gustaf Edgren; Henrik Ullum; Klaus Rostgaard; Christian Erikstrup; Ulrik Sartipy; Martin J Holzmann; Olof Nyrén; Henrik Hjalgrim
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.